Zenith Drugs Limited (NSE:ZENITHDRUG)

India · Delayed Price · Currency is INR

40.45

+0.85 (2.15%)

Nov 11, 2026, 10:52 AM IST

Market Cap	693.67M -35.9%
Revenue (ttm)	1.71B +28.4%
Net Income	39.43M -44.9%
EPS	2.30 -44.9%
Shares Out	17.15M
PE Ratio	17.59
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,400
Open	40.35
Previous Close	39.60
Day's Range	40.30 - 40.45
52-Week Range	33.30 - 61.95
Beta	1.39
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 13, 2026

About Zenith Drugs

Zenith Drugs Limited, together with its subsidiaries, manufactures and trades in branded, generic, and OTC medicines in India and internationally. The company offers a range of pharmaceutical formulations, such as ORS powder, liquid oral solutions, lotions and liquid external solutions, ointments and creams, gels, capsules, and tablets. Its products are used for analgesic and anti-inflammatory, anti-cold and anti-allergic, vitamin and nutraceutical, respiratory care, gynecology, pediatric care, dermatology, orthopedic care, critical care inject... [Read more]

Industry Medical - Pharmaceuticals

Sector Healthcare

Founded 1956

Employees 172

Stock Exchange National Stock Exchange of India

Ticker Symbol ZENITHDRUG

Full Company Profile

Financial Performance

In fiscal year 2026, Zenith Drugs's revenue was 1.71 billion, an increase of 28.43% compared to the previous year's 1.33 billion. Earnings were 39.43 million, a decrease of -44.94%.

Financial Statements